Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Toxicol Rep. 2014;1:214–223. doi: 10.1016/j.toxrep.2014.03.005

Figure 5.

Figure 5

Time-concentration profiles of TBBPA in plasma following A: oral administration, 5 min-24 h (250 mg/kg; N=3); B: IV administration, 5 min-6 h (25 mg/kg; N=4). Regression lines show model-predicted data. TBBPA was quantified by UV-detection at 210 nm following separation by HPLC (see Methods).